Comment | Published:

Does everyone develop covert cancer?

Nature Reviews Cancer volume 14, pages 209210 (2014) | Download Citation

Abstract

Around one in three individuals, if they live long enough, will have a confirmed clinical diagnosis of overt cancer, and there is increasing evidence that many of us — I contend all of us — develop covert cancer.

Do we all develop a covert cancer as we age?

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    et al. The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J. Urol. 150, 379–385 (1993).

  2. 2.

    & Using autopsy series to estimate the disease “reservoir” for ductal carcinoma in situ of the breast: how much more breast cancer can we find? Ann. Int. Med. 127, 1023–1028 (1997).

  3. 3.

    et al. Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proc. Natl Acad. Sci. USA 99, 8242–8247 (2002).

  4. 4.

    et al. Sun-induced nonsynonymous p53 mutations are extensively accumulated and tolerated in normal appearing human skin. J. Invest. Dermatol. 131, 504–508 (2011).

  5. 5.

    et al. The origin and evolution of mutations in acute myeloid leukemia. Cell 150, 264–278 (2012).

  6. 6.

    Darwinian medicine: a case for cancer. Nature Rev. Cancer 7, 213–221 (2007).

  7. 7.

    & Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nature Med. 17, 320–329 (2011).

  8. 8.

    , Jr & Overdiagnosis and overtreatment in cancer: an opportunity for improvement. J. Am. Med. Assoc. 310, 797–798 (2013).

  9. 9.

    et al. Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nature Genet. 38, 468–473 (2006).

  10. 10.

    et al. NSAIDs modulate clonal evolution in Barrett's esophagus. PLoS Genet. 9, e1003553 (2013).

Download references

Author information

Affiliations

  1. Centre for Evolution and Cancer, The Institute of Cancer Research, Brookes Lawley Building, 15 Cotswold Road, Sutton, Surrey SM2 5NG, UK.

    • Mel Greaves

Authors

  1. Search for Mel Greaves in:

Competing interests

The author declares no competing financial interests.

Corresponding author

Correspondence to Mel Greaves.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nrc3703

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing